The CASPR Group, which has partnered with the Association for Professionals in Infection Control and Epidemiology (APIC) as a Strategic Resource Partner for 2019, has announced plans to introduce its new product CASPR Medik (pronounced medic) during the Annual APIC conference held June 12-14 in Philadelphia.
In a press statement, industry expert John LaRochelle says people can expect to see “the holy grail in terms of what we’ve been looking for in the industry for cleaning and disinfection to fill the gap between what the housekeepers miss for cleaning and disinfection, and what these enhanced disinfection devices just can’t hit.”
The company says the CASPR technology has been installed and studied in several hospital trials. Results to date have demonstrated up to an 80 percent reduction in bacterial and fungal micro-burdens and a significant reduction in the incidence of MRSA and VRE. Departments being trialed have also experienced a large reduction in employee absenteeism.
According to company literature, the device is based on technology developed to protect the astronauts in the International Space Station. Once inserted into the ducts of an HVAC system, CASPR Medik reacts with the H2O molecules found in the air to continuously create highly effective oxidizing molecules, which are delivered at safe levels to all surfaces. This technology continuously reduces the level of clinically relevant pathogens facility wide without requiring additional resources or interrupting patient care.
“You couldn’t ask for anything better,” says current customer Lori Townsend, MSN, CIC, CPHQ in the statement. “CASPR is continuous disinfection. You don’t have to have the staff involved because it is no-touch. It is completely automated.”
